Arkolith/Insider Trading/CBAY/Form 4

Shah Sujal

Chief Executive Officer, DirectorCymaBay Therapeutics, Inc. (CBAY) · full profile →Form 4 · filed Mar 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
18
9 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2024Option exercise(M)3K$11.69$37K368K
Mar 13, 2024Option exercise(M)1$2.94$3407K
Mar 13, 2024Option exercise(M)2K$5.78$13K407K
Mar 13, 2024Option exercise(M)22K$4.05$89K404K
Mar 13, 2024Option exercise(M)14K$8.43$121K382K
Mar 13, 2024Option exercise(M)12K$10.00$116K279K
Mar 13, 2024Option exercise(M)15K$1.06$16K294K
Mar 13, 2024Option exercise(M)52K$1.72$90K346K
Mar 13, 2024Option exercise(M)19K$9.21$174K365K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2024Option exercise(M)15K—$00
Mar 13, 2024Option exercise(M)52K—$00
Mar 13, 2024Option exercise(M)1—$036K
Mar 13, 2024Option exercise(M)3K—$00
Mar 13, 2024Option exercise(M)14K—$00
Mar 13, 2024Option exercise(M)22K—$00
Mar 13, 2024Option exercise(M)2K—$013K
Mar 13, 2024Option exercise(M)12K—$00
Mar 13, 2024Option exercise(M)19K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-006513) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML